Economic burden of asthma: a systematic review.
Economic burden of asthma: a systematic review.
复制标题
DOI：
10.1186/1471-2466-9-24
复制
发表时间：
2009-05-19
影响因子：
3.1
通讯作者：
FitzGerald, J Mark
中科院分区：
文献类型：
--
作者：
Bahadori, Katayoun;Doyle-Waters, Mary M;FitzGerald, J Mark
背景：哮喘与巨大的医疗费用有关，包括直接和间接费用。它还与发病率和死亡率相关的未来潜在收入损失有关。方法：系统检索MEDLINE、EMBASE、CINAHL、CDSR、OHE-HEED和Web of Science数据库1966 - 2008年的相关文献。住院和药物被认为是直接成本中最重要的成本驱动因素。工作和学校损失占间接费用的最大比例。哮喘的费用与合并症、年龄和疾病严重程度相关。结论：尽管有有效的预防性治疗，但与哮喘相关的费用仍在增加。需要采取包括对患者和医生进行教育以及定期随访的策略来减轻哮喘的经济负担。
BACKGROUND: Asthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma.METHODS: We performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008.RESULTS: Sixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity.CONCLUSION: Despite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.